期刊
CHEMICAL ENGINEERING JOURNAL
卷 411, 期 -, 页码 -出版社
ELSEVIER SCIENCE SA
DOI: 10.1016/j.cej.2021.128568
关键词
BiAgOS; Photodynamic therapy; Photothermal therapy; CT imaging; Ball-milling
资金
- National Natural Science Foundation of China [NSFC 51972076, 51972075, 51772059]
- Natural Science Foundation of Heilongjiang Province [ZD2019E004]
- Natural Science Foundation of Shandong Province [ZR2019ZD29]
- Postdoctoral Scientific Research Developmental Fund [LBH-Q18034]
- Fundamental Research funds for the Central Universities
The study fabricated spherical BiAgOS nano particles using ball-milling method as a photosensitizer for both PDT and PTT therapy, showing excellent biocompatibility and tumor cell inhibition effects in vitro and in vivo experiments. The results provide a promising strategy to develop similar materials for imaging-guided tumor treatment with NIR light.
Photodynamic therapy (PDT) and photothermal therapy (PTT) combined treatment guided by imaging diagnosis has brought the cancer treatment into a new stage. But simple nanoplatforms with multifunctional therapeutic performance are rarely designed. Herein, we adopt ball-milling method to fabricate spherical BiAgOS nano particles as photosensitizer to apply for 808 nm near-infrared (NIR) light triggered PDT and PTT co-therapy. The polyethylene glycol (PEG) modified BiAgOS NPs show a great absorption in the range of visible light to near infrared region. Under 808 nm laser irradiation, BiAgOS-PEG NPs have obvious photothermal and photosensitive effects together with excellent X-ray computed tomography (CT) imaging function. The in vitro and in vivo experiments exhibit that the BiAgOS-PEG NPs have good biocompatibility, excellent tumor cells inhibition effects simultaneously. Our finding described the first use of BiAgOS-PEG NPs as a semiconductor photosensitizer for anti-cancer treatment, providing a promising strategy to fabricate this kind of material for imaging guided NIR light induced combined tumor treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据